Experience Fenwick Represents Sema4 in Combination Agreement With CM Life Sciences SPAC February 9, 2021
Experience Fenwick Represents Veracyte in Pending $600M Acquisition of Decipher Biosciences and $550M Public Offering February 5, 2021